Leukemia Clinical Trials in Michigan

Showing 1141-1160 of 1,237 trials

COMPLETEDPhase 241 miles

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

NCT00684918

This protocol will evaluate the efficacy of obatoclax in older patients with previously untreated AML.

AML

Gemin X18 participantsStarted Apr 2008

Chicago, Illinois, United States • Iowa City, Iowa, United States • Westwood, Kansas, United States +10 more locations

COMPLETEDPhase 348 miles

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00005977

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have non-Hodgkin's lymphoma or acute lymphocytic leukemia.

LeukemiaLymphoma

Children's Oncology Group83 participantsStarted Sep 2000

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +116 more locations

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Leukemia Trials in Other Cities

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Study on OsseoSpeed™ Implants in Patients Missing 2-5 Teeth in the Posterior Lower Jaw, Restored With Permanent Teeth Attached 6-7 Weeks Later

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Other Conditions in Michigan